A Safety and Feasibility Study of Mitotane in Prostate Cancer

Summary

1. The primary objective of this study is to assess the feasibility of treating patients with metastatic castration resistant prostate cancer with mitotane. Secondary objectives are to assess safety and tolerability as well as response rate of therapy 2. To assess the toxicity of Mitotane in men with HRPC 3. To assess the relationship between baseline serum adrenal androgens and their response to Mitotane

Timeline

Start

2013-09

Primary completion

2015-04

Completion

2015-10

Drugs

Indications